• Product NameRivaroxaban
• Brief DescriptionInhibitors
• Purification99.50%
• Biological ActivityRivaroxaban is an anticoagulant and the first orally active direct factor Xa inhibitor. Unlike warfarin, routine lab monitoring of INR is not necessary.
• Target NameFactor Xa inhibitor; Thrombin inhibitor
• CAS No. 366789-02-8
• Calculated MW 435.88
• Formulation C19H18ClN3O5S
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cardiovascular System
  SMILES:C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl
  Pathways:Metabolism; Others
  Receptor:Factor Xa; Thrombin
  Boling pt:732.6C?
  Melting pt:228-229C
  Solubility:DMSO: 87 mg/mL (199.59 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Perzborn E, et al. J Thromb Haemost, 2005, 3(3), 514C521.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting